Veterinary Medicine Market by Mode of Delivery (Oral, Parenteral), Product (Biologics, Medicated Feed Additives, Pharmaceuticals), Animal Type, End-user - Global Forecast 2024-2030

Veterinary Medicine Market by Mode of Delivery (Oral, Parenteral), Product (Biologics, Medicated Feed Additives, Pharmaceuticals), Animal Type, End-user - Global Forecast 2024-2030


The Veterinary Medicine Market size was estimated at USD 30.21 billion in 2023 and expected to reach USD 32.47 billion in 2024, at a CAGR 7.69% to reach USD 50.78 billion by 2030.

The veterinary medicine market encompasses a broad range of medical products, services, and solutions to prevent, diagnose, and treat diseases in animals. This market serves a crucial role in ensuring the health and well-being of pet animals and maintaining the productivity and health of livestock worldwide. This market caters to companion animals such as dogs, cats, and horses and livestock, including cattle, pigs, and poultry. Veterinary medicines find application in various fields, including biosecurity, nutrition, and animal welfare, covering many end uses, from routine healthcare and preventive measures to emergency treatments. The primary users are veterinary hospitals and clinics, livestock farms, and sometimes pet owners directly. The end-use is driven by the necessity for maintaining animal health, ensuring livestock productivity, and preventing disease transmission from animals to humans. The veterinary medicine market is driven by several factors, including rising awareness of animal health and wellness, increasing ownership of companion animals alongside a willingness to spend on animal healthcare, growing demand for protein-rich diets leading to a need for healthier livestock, and government initiatives and regulations promoting animal health. However, the veterinary medicine market faces several challenges, including high costs of veterinary healthcare services and products, stringent regulatory approval processes for veterinary drugs and products, and limited access to veterinary care in underdeveloped and developing regions. On the other hand, the development of personalized medicine through genetic testing and tailored treatment plans, expansion of telemedicine and digital technologies for remote diagnostics and treatment, innovation in biotechnology for novel vaccines and therapeutics, and environmental sustainability in veterinary practice and animal agriculture present numerous opportunities for innovation and growth of the veterinary medicine market.

Regional Insights

In the United States, the veterinary medicine market is driven by high pet adoption rates and advanced healthcare infrastructure. Consumers strongly prefer premium, preventive medicines and are increasingly aware of animal health issues. Canada has high standards of animal care and significant expenditure on pet health. The market shows a leaning towards organic and natural veterinary products. Government initiatives promoting animal welfare have also encouraged growth in this sector. The South American market is witnessing growth due to the rising adoption of pet animals and increasing expenditure on animal health. Brazil and Argentina are at the forefront of the regional market owing to their large livestock populations and escalating demand for meat and dairy products. APAC is emerging as a rapidly growing region for veterinary medicine due to its expanding pet population, increasing disposable earnings, and raising awareness of animal health. China and India are at the forefront of the region's growth, fueled by their large livestock sectors and increasing pet adoption rates. Japan presents a mature market with high consumer awareness about pet health. The country strongly emphasizes innovation, with numerous patents filed for veterinary pharmaceuticals and technology solutions designed to enhance animal welfare and management. The EU states have stringent regulations governing animal health and veterinary products. This region has a robust veterinary healthcare system and high consumer demand for sustainable and ethical products. Research and investment are strongly directed towards biotechnology and precision medicine to enhance animal health outcomes. In the Middle East, the market is developing with increasing awareness about animal health, especially in the pet sector. Africa's veterinary medicine market faces challenges such as limited access to veterinary services and prevalent animal diseases. However, international collaborations and NGO activities aim to improve the situation by focusing on disease eradication and capacity building for veterinary services.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Veterinary Medicine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
  • Rapid growth in global livestock population due to rising demand for meat and dairy production
  • Rise in pet adoption rates
  • Increasing cases of zoonotic and chronic diseases
Market Restraints
  • High influx of counterfeit drugs
Market Opportunities
  • Rising R&D and procedural advancements in vet medicine
  • Rising spending on pet care in urban areas
Market Challenges
  • Short product exclusivity period
Market Segmentation Analysis
  • Product: Increasing preference for biologics to manage diseases in animals
  • End-user: Expanding usage of veterinary medicines at veterinary hospitals and clinics
Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Veterinary Medicine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Veterinary Medicine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

ENTOD Pharma forays into veterinary eye and ear care with ‘FUR’

Entod Pharmaceuticals Ltd. introduced its latest division, 'FUR, ' which is dedicated to advancing veterinary ophthalmic and otic health. This innovative segment promises a comprehensive suite of treatments tailored for pets, from hydrating lubricants to advanced therapies against glaucoma, allergies, and infections, alongside multifaceted combination products.

FDA approves first animal drug for Giardia duodenalis, additional drugs for cows, swine

The Food and Drug Administration (FDA) granted approvals for innovative animal drugs, enhancing treatment options in veterinary medicine. This approval came for Ayradia by Virbac Animal Health, a metronidazole oral suspension, marking the first FDA-approved medication for combating Giardia duodenalis infections in dogs.

Zoetis officially launches 2 FDA approved drugs in the US veterinary market

Zoetis Inc. introduced two groundbreaking FDA-approved drugs to the US veterinary market, marking significant advancements in canine healthcare. The FDA approved Bedinvetmab injection for managing osteoarthritis pain in dogs and Oclacitinib chewable tablets for treating pruritus related to allergic and atopic dermatitis in dogs aged one year and above.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Veterinary Medicine Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Medicine Market, highlighting leading vendors and their innovative profiles. These include Archer-Daniels-Midland Company, Biogenesis Bago SA, Biopharm company, Biowet Puławy sp. z o.o., Brovapharma, C. H. Boehringer Sohn AG & Co. KG, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Indian Immunologicals Ltd, Intracin Pharmaceutical Private Limited, JoinHub Pharma, Merck & Co. Inc., Nam Pharma Sdn Bhd, NAPHAVET Co., Ltd., Neogen Corporation, Nutreco N.V., Phibro Animal Health Corporation, Sykes Vet International Pty Ltd., TRAVETCO, Vetoquinol S.A., Vetpharma Animal Health S.L., Vetsintez LLC, Virbac SA, Weefsel Pharma, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Mode of Delivery
  • Oral
  • Parenteral
  • Product
  • Biologics
  • DNA Vaccines
  • Inactivated Vaccines
  • Live attenuated vaccines
  • Recombinant Vaccines
  • Medicated Feed Additives
  • Pharmaceuticals
  • Analgesics
  • Anti-infectives
  • Anti-inflammatory
  • Parasiticides
  • Animal Type
  • Companion
  • Cats
  • Dogs
  • Horses
  • Production
  • Cattle
  • Fish
  • Poultry
  • Sheep & Goats
  • Swine
  • End-user
  • Point-of-care Testing/In-House Testing
  • Reference Laboratories
  • Veterinary Hospitals & Clinics
  • Region
  • Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom


Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid growth in global livestock population due to rising demand for meat and dairy production
5.1.1.2. Rise in pet adoption rates
5.1.1.3. Increasing cases of zoonotic and chronic diseases
5.1.2. Restraints
5.1.2.1. High influx of counterfeit drugs
5.1.3. Opportunities
5.1.3.1. Rising R&D and procedural advancements in vet medicine
5.1.3.2. Rising spending on pet care in urban areas
5.1.4. Challenges
5.1.4.1. Short product exclusivity period
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing preference for biologics to manage diseases in animals
5.2.2. End-user: Expanding usage of veterinary medicines at veterinary hospitals and clinics
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Veterinary Medicine Market, by Mode of Delivery
6.1. Introduction
6.2. Oral
6.3. Parenteral
7. Veterinary Medicine Market, by Product
7.1. Introduction
7.2. Biologics
7.3. Medicated Feed Additives
7.4. Pharmaceuticals
8. Veterinary Medicine Market, by Animal Type
8.1. Introduction
8.2. Companion
8.3. Production
9. Veterinary Medicine Market, by End-user
9.1. Introduction
9.2. Point-of-care Testing/In-House Testing
9.3. Reference Laboratories
9.4. Veterinary Hospitals & Clinics
10. Americas Veterinary Medicine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Veterinary Medicine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Veterinary Medicine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. ENTOD Pharma forays into veterinary eye and ear care with ‘FUR’
13.3.2. FDA approves first animal drug for Giardia duodenalis, additional drugs for cows, swine
13.3.3. Zoetis officially launches 2 FDA approved drugs in the US veterinary market
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings